India Platelet Rich Plasma (Prp) Market Size & Outlook
The platelet rich plasma (prp) market in India is expected to reach a projected revenue of US$ 118.2 million by 2033. A compound annual growth rate of 15.9% is expected of India platelet rich plasma (prp) market from 2026 to 2033.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, India platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2033.
Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 97.6 million by 2033.
The demand for PRP therapy has grown significantly, particularly among patients experiencing hair loss and skin issues such as pigmentation & ulcers. Over the past few years, the popularity of PRP therapy has surged due to its favorable results and minimal adverse effects. In some hospitals, the Outpatient Departments (OPD) of dermatology or skin branches see an influx of 30 to 40 patients seeking PRP treatment.
The therapy has garnered widespread acceptance, supported by extensive global research. Patients in need of this treatment are recommended and often choose PRP therapy, although alternative treatments are available as well in some cases.
This trend is particularly notable in hospitals in India. Moreover, the Department of Spine, Pain, and Palliative Care at Central Hospital South Eastern Railway began utilizing PRP therapy to treat conditions, such as partial supraspinatus tear in the right shoulder joint. This introduction of PRP therapy within the Indian Railways system signifies an emerging opportunity and potential market growth for its applications in diverse medical fields and patient needs.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Platelet Rich Plasma (PRP) Market Outlook will help companies and investors design strategic landscapes.
Pure Prp was the largest segment with a revenue share of 57.58% in 2025.
Horizon Databook has segmented the India platelet rich plasma (prp) market based on pure prp, leukocyte rich prp, others type covering the revenue growth of each sub-segment from 2021 to 2033.
The demand for PRP therapy has grown significantly, particularly among patients experiencing hair loss and skin issues such as pigmentation & ulcers. Over the past few years, the popularity of PRP therapy has surged due to its favorable results and minimal adverse effects. In some hospitals, the Outpatient Departments (OPD) of dermatology or skin branches see an influx of 30 to 40 patients seeking PRP treatment.
The therapy has garnered widespread acceptance, supported by extensive global research. Patients in need of this treatment are recommended and often choose PRP therapy, although alternative treatments are available as well in some cases.
This trend is particularly notable in hospitals in India. Moreover, the Department of Spine, Pain, and Palliative Care at Central Hospital South Eastern Railway began utilizing PRP therapy to treat conditions, such as partial supraspinatus tear in the right shoulder joint. This introduction of PRP therapy within the Indian Railways system signifies an emerging opportunity and potential market growth for its applications in diverse medical fields and patient needs.
India Platelet Rich Plasma (Prp) Market Type Outlook (Revenue, USD Million , 2021-2033)
Pure PRP
Leukocyte Rich PRP
Others Type
India Platelet Rich Plasma (Prp) Market Application Outlook (Revenue, USD Million , 2021-2033)
Orthopedics
Sports Medicine
Cosmetic Surgery
Dermatology
Ophthalmic Surgery
Neurosurgery
General Surgery
Others Application
India Platelet Rich Plasma (Prp) Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Clinics
Others End Use
Reasons to subscribe to Platelet Rich Plasma (PRP) Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Platelet Rich Plasma (PRP) Market Outlook databook
Our clientele includes a mix of Platelet Rich Plasma (PRP) Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India Platelet Rich Plasma (PRP) Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into India Platelet Rich Plasma (PRP) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
India Platelet Rich Plasma (Prp) Market, 2021-2033 (US$M)